CN102114024B - 预防月经期偏头痛的复方雌谷胶囊 - Google Patents
预防月经期偏头痛的复方雌谷胶囊 Download PDFInfo
- Publication number
- CN102114024B CN102114024B CN2009102561353A CN200910256135A CN102114024B CN 102114024 B CN102114024 B CN 102114024B CN 2009102561353 A CN2009102561353 A CN 2009102561353A CN 200910256135 A CN200910256135 A CN 200910256135A CN 102114024 B CN102114024 B CN 102114024B
- Authority
- CN
- China
- Prior art keywords
- capsules
- menstrual period
- migraine
- vitamin
- cigu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明属于医药技术领域,公开了一种预防月经期偏头痛的复方雌谷胶囊,它是以尼尔雌醇、谷维素、维生素B1、维生素B2为原料,根据每种药物原料不同特征,分别按比例配置,经低温干燥、研细、调匀、灭菌等处理,制成一种胶囊。本发明具有可有效补充月经期间骤降的雌二醇,缓解患者的焦虑、紧张情绪,减少月经性偏头痛的发作次数,减轻月经性偏头痛的发作程度,提高了患者的生活质量等优点,且配方新、药物配置原料来源广泛、廉价、制作方便、药品成本低,无不良反应,患者易接受。经临床150例月经性偏头痛患者使用,总有效率达96%,未见特殊毒副作用。
Description
技术领域
本发明属药品,具体讲是一种预防月经期偏头痛的复方雌谷胶囊。
背景技术
月经期偏头痛是一种与卵巢周期变化有关的特殊类型的偏头痛,占女性偏头痛的60%以上,常常发生在月经前1~7天、月经期或月经后1~2天,经期头痛加重,每月发作1次或1次以上,往往有家族遗传史。研究发现,偏头痛的发作与月经前雌二醇的骤降有密切关系,而与黄体酮下降无明显关系。近几年注意到精神状态、紧张和疲劳等是偏头痛发作的诱发因素。临床上多采用镇痛、止吐、麦角胺类药物治疗。麦角胺类是5-羟色胺(5-HT)受体的促动剂,主要激动5-HTIA受体,但对多巴胺、肾上腺素受体也有作用,其过量会出现恶心、呕吐、腹痛、肌痛及周围血管痉挛、缺血等不良作用。近年5-HTIA/ID激动药曲普坦、左米曲坦治疗偏头痛有新突破,但药源受限制,且价格偏高,不能广泛应用于临床。
发明内容
本发明的目的在于提供一种预防月经期偏头痛的有效率高、副作用小、费用低的复方雌谷胶囊。
本发明的目的是通过以下方式实现的:一种预防月经期偏头痛的复方雌谷胶囊,该复方雌谷胶囊是由尼尔雌醇、谷维素、维生素B1、维生素B2四种西药成份组成,其特征在于复方雌谷胶囊中各种药物重量百分比分别为:尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%。根据月经期偏头痛发病机制,尼尔雌醇为雌三醇衍生物,为长效雌激素,有较强的雌激素作用,其口服雌激素活性为炔雌醚的3倍,作用维持时间较长。谷维素主要存在于毛糠油及其油脚中,其主要功能为抗氧化、抗衰老,可改善植物神经功能失调、内分泌平衡障碍及精神神经失调。同时能稳定情绪、减轻焦虑及紧张状态,并改善睡眠。维生素B2促进细胞内氧化-还原反应,维持线粒体的正常功能。维生素B1在维持神经系统的正常功能中起重要作用。该复方雌谷胶囊经临床150例月经性偏头痛患者试验,可有效补充月经期间骤降的雌二醇,缓解患者的焦虑、紧张情绪,减少月经性偏头痛的发作次数,减轻月经性偏头痛的发作程度,提高了患者的生活质量。且配方新、药物配置原料来源广泛、廉价、制作方便、药品成本低,无不良反应,患者易接受。
预防月经期偏头痛的复方雌谷胶囊的配制方法如下:分别将尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%按比例配置,经低温干燥、研细、调匀、灭菌等处理,分装胶囊,每粒胶囊含药粉0.1g,按每瓶30粒胶囊装瓶,封口,贴签。于月经前9~10天口服,每次2粒,每日1次,月经结束后停服。治疗3个月为一疗程。
本复方雌谷胶囊适用于月经期偏头痛患者。治疗期间应避免过度劳累,用药后30分钟内不得服用其他药物。
实施例:将500mg尼尔雌醇、10300mg谷维素、4200mg维生素B1、5000mg维生素B2经低温干燥、研细、调匀、灭菌等处理,分装胶囊,每粒胶囊含药粉0.1g,按每瓶30粒胶囊装瓶,封口,贴签。
Claims (1)
1.预防月经期偏头痛的复方雌谷胶囊,其特征是由尼尔雌醇、谷维素、维生素B1、维生素B2四种西药成份组成,各种药物重量百分比分别为:尼尔雌醇2%-3%、谷维素50%-52%、维生素B120%-22%、维生素B224%-26%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102561353A CN102114024B (zh) | 2009-12-30 | 2009-12-30 | 预防月经期偏头痛的复方雌谷胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102561353A CN102114024B (zh) | 2009-12-30 | 2009-12-30 | 预防月经期偏头痛的复方雌谷胶囊 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102114024A CN102114024A (zh) | 2011-07-06 |
CN102114024B true CN102114024B (zh) | 2012-05-30 |
Family
ID=44213024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102561353A Expired - Fee Related CN102114024B (zh) | 2009-12-30 | 2009-12-30 | 预防月经期偏头痛的复方雌谷胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102114024B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102114024B (zh) * | 2009-12-30 | 2012-05-30 | 宋杰 | 预防月经期偏头痛的复方雌谷胶囊 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1079396A (zh) * | 1992-12-20 | 1993-12-15 | 淄博市淄川区第二制药厂 | 增智药物制剂增智素 |
IE61350B1 (en) * | 1986-08-04 | 1994-11-02 | Univ Florida | Method for treating male sexual dysfunction |
CN1199614A (zh) * | 1997-05-20 | 1998-11-25 | 黄茹 | 中老年妇女保健药 |
CN1257707A (zh) * | 1999-05-31 | 2000-06-28 | 宋晓恩 | 一种改善老年人生命活力的保健药及配方 |
CN102114024A (zh) * | 2009-12-30 | 2011-07-06 | 宋杰 | 预防月经期偏头痛的复方雌谷胶囊 |
-
2009
- 2009-12-30 CN CN2009102561353A patent/CN102114024B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61350B1 (en) * | 1986-08-04 | 1994-11-02 | Univ Florida | Method for treating male sexual dysfunction |
CN1079396A (zh) * | 1992-12-20 | 1993-12-15 | 淄博市淄川区第二制药厂 | 增智药物制剂增智素 |
CN1199614A (zh) * | 1997-05-20 | 1998-11-25 | 黄茹 | 中老年妇女保健药 |
CN1257707A (zh) * | 1999-05-31 | 2000-06-28 | 宋晓恩 | 一种改善老年人生命活力的保健药及配方 |
CN102114024A (zh) * | 2009-12-30 | 2011-07-06 | 宋杰 | 预防月经期偏头痛的复方雌谷胶囊 |
Non-Patent Citations (3)
Title |
---|
孟琳等.尼尔雌醇治疗流动育龄妇女继发性闭经39例体会.《齐齐哈尔医学院学报》.2007,(第10期),1203-1204. * |
郭述苏等.月经期与偏头痛相关的研究.《中国疼痛医学杂志》.1995,(第01期),7-10. * |
饶志青等.激素替代疗法治疗围绝经期妇女灼口征的体会.《遵义医学院学报》.2003,第26卷(第05期),466-467. * |
Also Published As
Publication number | Publication date |
---|---|
CN102114024A (zh) | 2011-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vijayakumar et al. | Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia | |
Vijayakumar et al. | Drug-induced dyskinesia, part 2: treatment of tardive dyskinesia | |
Vaswani et al. | Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review | |
AU2024203369A1 (en) | Methods and compositions for enhancing health | |
Gonzalez-Latapi et al. | Non-dopaminergic treatments for motor control in Parkinson’s disease: an update | |
WO2016145910A1 (zh) | Nadh和nmn在制备帕金森病药物或保健品的应用 | |
Rindone et al. | Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding | |
JP2012236834A5 (zh) | ||
JP2005525329A (ja) | 向精神薬とセレンから成る配合物 | |
Powers et al. | Pharmacotherapy for eating disorders and obesity | |
CN102198108B (zh) | 一种盐酸西那卡塞片剂或胶囊制备工艺 | |
CN102114024B (zh) | 预防月经期偏头痛的复方雌谷胶囊 | |
CN101306011B (zh) | 一种用于综合降血压的功能食品 | |
CN106667903A (zh) | 一种治疗白癜风的氟西汀酊剂 | |
Seamon et al. | Ephedra: yesterday, DSHEA, and tomorrow—a ten year perspective on the Dietary Supplement Health and Education Act of 1994 | |
JP2018138582A (ja) | キトオリゴ糖を含有するアミラーゼ活性阻害用組成物 | |
Peralta | Depression: It Matters! | |
US20150273007A1 (en) | Blood pressure reduction with dietary supplements | |
JP2009196972A (ja) | 医薬組成物 | |
Dickerson et al. | Pharmacotherapy for the obese patient | |
Ajagun-Ogunleye et al. | Hypoglycemic and high dosage effects of bidens pilosa in type-1 diabetes mellitus | |
NL2005194C2 (en) | Pharmaceutical composition for use in the prevention and treatment of gingivitis and parodontitis. | |
RU2530628C1 (ru) | Фармацевтическая композиция и набор для лечения и/или предупреждения нарушений, связанных с ожирением, и способ лечения и/или предупреждения нарушений, связанных с ожирением | |
JP2007137896A (ja) | イブプロフェン含有医薬製剤 | |
Chen et al. | Mitigation of high-fat diet-induced sarcopenia by Toona sinensis fruit extracts via autophagic flux and mitochondrial quality control |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20121230 |